Targeting SARS-CoV2 Spike Protein Receptor Binding Domain by Therapeutic Antibodies
Authors:
- Arif HussainAHArif Hussain
- Anwarul HasanAnwarul Hasan
- Mohammad Mahdi Nejadi BabadaeiMBMohammad Mahdi Nejadi Babadaei
- Samir Haj BloukhSamir Haj Bloukh
- Muhammad E.H. ChowdhuryMuhammad E.H. Chowdhury
- Majid SharifiMajid Sharifi
- Setareh HaghighatSHSetareh Haghighat
- Mojtaba FalahatiMFMojtaba Falahati
Open Access
- 1 October 2020
- journal article
- review article
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 130, 110559
Abstract
No abstract availableKeywords
Funding Information
- Qatar Foundation (GCC-2017-005)
- Qatar National Research Fund
- Qatar University
This publication has 51 references indexed in Scilit:
- Therapeutic Options for Middle East Respiratory Syndrome Coronavirus (MERS-CoV) – possible lessons from a systematic review of SARS-CoV therapyInternational Journal of Infectious Diseases, 2013
- Neutralizing human monoclonal antibodies to severe acute respiratory syndrome coronavirus: target, mechanism of action, and therapeutic potentialReviews in Medical Virology, 2011
- Structural Insights into Immune Recognition of the Severe Acute Respiratory Syndrome Coronavirus S Protein Receptor Binding DomainJournal of Molecular Biology, 2009
- Structural Basis for Potent Cross-Neutralizing Human Monoclonal Antibody Protection against Lethal Human and Zoonotic Severe Acute Respiratory Syndrome Coronavirus ChallengeJournal of Virology, 2008
- Mechanisms of Zoonotic Severe Acute Respiratory Syndrome Coronavirus Host Range Expansion in Human Airway EpitheliumJournal of Virology, 2008
- Potent cross-reactive neutralization of SARS coronavirus isolates by human monoclonal antibodiesProceedings of the National Academy of Sciences, 2007
- Human Monoclonal Antibody Combination against SARS Coronavirus: Synergy and Coverage of Escape MutantsPLOS Medicine, 2006
- Evaluation of Human Monoclonal Antibody 80R for Immunoprophylaxis of Severe Acute Respiratory Syndrome by an Animal Study, Epitope Mapping, and Analysis of Spike VariantsJournal of Virology, 2005
- Molecular and Biological Characterization of Human Monoclonal Antibodies Binding to the Spike and Nucleocapsid Proteins of Severe Acute Respiratory Syndrome CoronavirusJournal of Virology, 2005
- An efficient method to make human monoclonal antibodies from memory B cells: potent neutralization of SARS coronavirusNature Medicine, 2004